Developer says Russia's CoviVac COVID-19 vaccine effective against Delta variant
The Peninsula
MOSCOW: The developer of CoviVac, one of Russia's vaccines against COVID-19, said on Wednesday it is effective against the highly infectious Delta variant, TASS news agency reported.
Russia is trying to contain a rise in cases and deaths and has introduced mandatory vaccination in Moscow and some other regions for a wide group of citizens, mainly using Sputnik V, Russia's flagship shot, the first of four domestic vaccines to be registered. Aidar Ishmukhametov, general director of the centre that developed CoviVac, said studies had showed it was equally effective against the Delta strain as against the Alpha strain of the virus.More Related News